Murdoch Children's Research Institute
Melbourne, Victoria, 3052, Australia
Location status: Recruiting
Location contact
Yasmin Jayasinghe
CONTACT
Yasmin Jayasinghe
PRINCIPAL_INVESTIGATOR
Zobaida Edib, MBBS, MPH, PhD
CONTACT
NCT Number: NCT06894810
The current standard of care for paediatric patients with cancer regarding preservation of their fertility (FP) is to provide high-quality information during the clinical consultation process. However, this approach depends on health provider knowledge and communication and has been shown to be sub-optimal in some situations. This impairs the critical decision-making of patients regarding fertility testing, utilization of gametes, and continuing payment of storage fees. The fertility preservation decision aid (FP DA) may lead to a greater understanding of their fertility status for participants. This knowledge may allow participants the opportunity to assess potential fertility issues prior to the end of their reproductive window, helping to minimize missed opportunities for parenthood.
This research study aims to assess the effectiveness of the use of the FP DA on unmet fertility information needs when it is provided in addition to high-quality information in parents of cancer survivors and CAYA cancer survivors compared to high-quality information alone.
Interested in participating?
Request Info16 year and older
All sexes
Interventional
Not applicable
Melbourne, Victoria, 3052, Australia
Location status: Recruiting
Yasmin Jayasinghe
CONTACT
Yasmin Jayasinghe
PRINCIPAL_INVESTIGATOR
Zobaida Edib, MBBS, MPH, PhD
CONTACT
Medical advances over recent decades have increased the overall survival rates of children, adolescents and young adults diagnosed with cancer, with survival rates now exceeding 80%. The pressure points are not only at diagnosis - research has shown that cancer treatment can potentially affect fertility later in life. Survivorship is an important time for addressing the following issues: fertility status, reproductive monitoring, decisions about interval fertility preservation, ongoing tissue storage and utilization. Options to preserve fertility are possible. Decision Aids (DA) have been developed to provide patients and their families with the required information to make informed reproductive health decisions that align with their values. The prevalence of fertility information needs that are unmet remains high at around 40% amongst cancer survivors. Research evaluating the effectiveness of DAs in survivorship is lacking.
This is a parallel group double-blind randomised controlled trial for parents and Child Adolescent and Young Adults (CAYA) cancer survivors assessing the Fertility Preservation Decision Aid (FP DA) when provided in conjunction with high-quality information.
Eligible participants will be randomly allocated to either a control group receiving high-quality information or a treatment group that will receive the FP DA in addition to high-quality information. Participants will be blinded to their group allocation as they will be instructed to review information regarding fertility preservation without informing them of the type of information they are reviewing.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Inclusion criteria
for both parents and survivors:
Inclusion criteria
for parents only:
Inclusion criteria
for survivors only
Exclusion criteria
Exclusion criteria
for both parents and survivors:
Exclusion criteria
for survivors only:
Decision Aids (DA) are evidence-based clinical tools developed for patients to supplement clinicians' discussions and facilitate difficult preference-sensitive decisions. They are the gold standard approach (recommended by the Australian Commission of Safety and Quality in Healthcare) to facilitate complex healthcare decisions where there is more than one reasonable choice and where patients may value benefits and risks differently.
Time frame: within 8 weeks from randomisation
Unmet information needs will be measured within 8 weeks post-randomisation using the Unmet Information Needs Scale. Items included in the questionnaire are: knowledge regarding fertility status, future parenthood goals, and information regarding fertility preservation procedures carried out at either the treatment or survivorship period. Needs are assessed on a 6-point scale, ranging from 0 to 5, with higher scores indicating greater unmet information needs.
Time frame: 6 months post-randomisation
Unmet fertility information needs will be measured at 6 months post-randomisation using the Unmet Information Needs Scale. Items included in the questionnaire are: knowledge regarding fertility status, future parenthood goals, and information regarding fertility preservation procedures carried out at either the treatment or survivorship period. Needs are assessed on a 6-point scale, ranging from 0 to 5, with higher scores indicating greater unmet information needs.
Time frame: within 8 weeks of randomisation, 6 months after randomisation
Changes in fertility knowledge will be measured using a purposively designed knowledge scale within 8 weeks of randomisation and at 6 months after randomisation. The knowledge scale that ranges from 0 to 6, with higher values indicated better knowledge.
Time frame: within 8 weeks of randomisation, 6 months after randomisation
Preparation for decision making will be measured by the utility of the information provided by participants using the Preparation for Decision Making Scale. The preparation for decision making scaling regarding fertility preservation comprises a 10 item scale with each answer scored 1 (not at all) to 5 (a great deal). The 10 items are summed and divided by 10. A higher score reflects greater preparation for decision making.
Time frame: within 8 weeks and 6 months after randomisation
Decisional conflict is defined as uncertainty around the decision to see a health professional for further advice about sexual and reproductive health and uncertainty around choices available to achieve parenthood. This will be measured using a validated decisional conflict scale. Scores range from 0 [feels extremely supported in decision making] to 100 [feels extremely unsupported in decision making].
Time frame: within 8 weeks of randomisation, 6 months after randomisation
Feasibility and acceptability of using the information resources will be measured using a validated feasibility and acceptability scale. They are assessed on a 5-point scale, ranging from 1 to 5, with higher scores indicating greater feasibility and acceptability.
Time frame: within 8 weeks of randomisation, 6 months after randomisation
FP DA usage analytic- bounce rate will be collected using a first-party analytics provider (Mixpanel).
Time frame: within 8 weeks of randomisation, 6 months after randomisation
FP DA usage analytic- average session duration will be collected using a first-party analytics provider (Mixpanel).
Time frame: within 8 weeks of randomisation, 6 months after randomisation
FP DA usage analytic- average time on pages will be collected using a first-party analytics provider (Mixpanel).
Time frame: within 8 weeks of randomisation, 6 months after randomisation
FP DA usage analytic- total number of pages view across the website per visit will be collected using a first-party analytics provider (Mixpanel).
Time frame: within 8 weeks of randomisation, 6 months after randomisation
FP DA usage analytic- user behavior flow will be collected using a first-party analytics provider (Mixpanel).
Time frame: within 8 weeks of randomisation, 6 months after randomisation
FP DA usage analytic- exit rate will be collected using a first-party analytics provider (Mixpanel).
Time frame: within 8 weeks of randomisation, 6 months after randomisation
FP DA usage analytic- returning users will be collected using a first-party analytics provider (Mixpanel).
Time frame: within 8 weeks of randomisation, 6 months after randomisation
FP DA usage analytic- heatmap will be collected using a first-party analytics provider (Mixpanel).
Time frame: within 8 weeks of randomisation, 6 months after randomisation
FP DA usage analytic- individual page rating will be collected using a first-party analytics provider (Mixpanel).
Time frame: within 8 weeks of randomisation, 6 months after randomisation
FP DA usage analytic- the proportion of values clarification exercises completed will be collected using a first-party analytics provider (Mixpanel).
Time frame: within 8 weeks of randomisation, 6 months after randomisation
FP DA usage analytic- the responses to the exercises completed will be collected using a first-party analytics provider (Mixpanel).
Time frame: within 8 weeks of randomisation, 6 months after randomisation
A five-point scale, ranging from 0 to 4, adapted from a Decision Aid (DA) development study will be used to assess the perceived usefulness of the information resources as a decision-making tool and whether it would have been helpful at the time of diagnosis. The higher scores will indicate greater perceived usefulness.
Contact information is provided by the study sponsor or research team.
Diana Navarro-Perez, PhD
CONTACT
Yasmin Jayasinghe, FRANZCOG, PhD
CONTACT
Murdoch Childrens Research Institute
Other
A Double Blind Randomised Controlled Trial of a Paediatric Fertility Preservation Decision Aid in Parents and Adolescents and Young Adults (CAYA) Cancer Survivors
Acronym: FOCUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.